Shareholders approve amalgamation of Dr. Agarwal's Eye Hospital into listed entity

Nclt Scheme FiledStrategic Transactions View source PDF Explain this filing

AGARWALEYE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.1%Reaction day

₹476.00

prior close

₹479.00

announcement price

After-mkt

timing

Nifty Microcap 250market-0.3%+0.4% vs market

Hospital peers, median of 23sector+0.4%-0.3% vs sector

On the reaction day the stock moved 0.4 pts more than Nifty Microcap 250 and 0.3 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.2

10m

-0.2

15m

-0.4

30m

-0.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.1-0.3+0.4+0.4-0.3

Next day

+0.6-0.1+0.8-0.1+0.7

-1.3-0.8-0.4-0.4-0.9

+0.4-2.8+3.3-2.9+3.3

+1.9-1.0+2.9-0.6+2.5

+0.6+0.4+0.2-0.7+1.3

+2.3-0.5+2.8-1.6+3.9

15d

+1.2-1.9+3.1-2.0+3.2

+1.3+0.4+0.8-1.9+3.1

+7.2+3.5+3.7-1.2+8.4

+1.6+2.0-0.4-9.4+11.0

UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 23Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Shareholders of Dr. Agarwal's Health Care approved the Scheme of Amalgamation with Dr. Agarwal's Eye Hospital (transferor) with 99.97 percent votes in favor (about 30.39 crore shares) at the NCLT convened meeting on July 2, 2026. Only 81,138 shares voted against. The merger will consolidate the eye hospital business into the listed entity, subject to NCLT and other regulatory approvals.

Likely market impact

Positive; internal group restructuring awaiting NCLT sanction. Simplifies structure by merging eye hospital into listed entity.